Lazard Asset Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,713
Closed -$42K 2093
2020
Q4
$42K Buy
+4,713
New +$36.5K ﹤0.01% 1446
2020
Q3
Sell
-7,489
Closed -$66K 1785
2020
Q2
$66K Buy
+7,489
New +$64.6K ﹤0.01% 1146

Other funds holding NPTN

Lazard Asset Management's NPTN Position: Q1 2021 in Review

Lazard Asset Management sold out of NEOPHOTONICS CORP (NPTN) in Q1 2021, closing a stake of 4,713 shares — an estimated $42K sold.

Lazard Asset Management first reported a position in NPTN in Q2 2020 and held it in 2 quarters. The position peaked at $66K in Q2 2020. 147 funds tracked by Wall St. Rank hold NPTN as of Q1 2021.

  • Lazard Asset Management reported no remaining NEOPHOTONICS CORP position as of Q1 2021 after selling out during the quarter.
  • Lazard Asset Management sold 4,713 NEOPHOTONICS CORP shares in Q1 2021, an estimated $42K.
  • Lazard Asset Management first reported a position in NEOPHOTONICS CORP in Q2 2020 and held it in 2 quarters.
  • Lazard Asset Management's NEOPHOTONICS CORP position peaked at $66K in Q2 2020.
  • 147 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2021.

Based on Lazard Asset Management's 13F filing for Q1 2021, filed 14 May 2021.